Showing results (401-410 of 431) with videos related to
Sort By:
Pageof 44
The Journal of Rheumatology|February 11, 1999
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domainsJ S Smolen, V Strand, M Cardiel, et al.The Journal of Rheumatology|February 24, 2000
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International ComparisonD D Gladman, C H Goldsmith, M B Urowitz, et al.Arthritis and Rheumatism|December 17, 2002
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trialE H S Choy, D A Isenberg, T Garrood, et al.Rheumatology (Oxford, England)|July 18, 2003
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset diseaseD A Isenberg, E Allen, V Farewell, et al.Lupus|May 29, 2012
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndromeC Janko, S André, L E Munoz, et al.Arthritis and Rheumatism|May 1, 1997
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosusD D Gladman, M B Urowitz, C H Goldsmith, et al.Journal of Autoimmunity|December 1, 1996
Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spousesP Youinou, D A Isenberg, J K Kalsi, et al.Annals of the Rheumatic Diseases|April 15, 2004
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritisC-S Yee, C Gordon, C Dostal, et al.Rheumatology (Oxford, England)|November 16, 2001
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathiesF W Miller, L G Rider, Y L Chung, et al.Annals of the Rheumatic Diseases|May 24, 2007
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000C-S Yee, D A Isenberg, A Prabu, et al.Pageof 44